However, despite an insignificant trend to lower mitotic indexes in patients with HER2-negative primary tumours which gave rise to HER2-low recurrences (P = 0.057), no significant differences in proliferation rates (mitosis scores and Ki67 expression) were found. The gene discussed is ERBB2; the disease is neoplasm.